| Product Code: ETC12973807 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Narcolepsy Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Narcolepsy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Narcolepsy Drugs Market - Industry Life Cycle |
3.4 Israel Narcolepsy Drugs Market - Porter's Five Forces |
3.5 Israel Narcolepsy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Narcolepsy Drugs Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Israel Narcolepsy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Israel Narcolepsy Drugs Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Israel Narcolepsy Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Narcolepsy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about narcolepsy and its treatment options in Israel |
4.2.2 Growing prevalence of narcolepsy in the Israeli population |
4.2.3 Technological advancements in narcolepsy drug development |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new narcolepsy drugs in Israel |
4.3.2 Limited availability of specialized healthcare professionals for narcolepsy diagnosis and treatment |
5 Israel Narcolepsy Drugs Market Trends |
6 Israel Narcolepsy Drugs Market, By Types |
6.1 Israel Narcolepsy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Narcolepsy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Israel Narcolepsy Drugs Market Revenues & Volume, By Stimulants, 2021 - 2031F |
6.1.4 Israel Narcolepsy Drugs Market Revenues & Volume, By Wakefulness-Promoting Agents, 2021 - 2031F |
6.1.5 Israel Narcolepsy Drugs Market Revenues & Volume, By Antidepressants, 2021 - 2031F |
6.1.6 Israel Narcolepsy Drugs Market Revenues & Volume, By Sodium Oxybate, 2021 - 2031F |
6.1.7 Israel Narcolepsy Drugs Market Revenues & Volume, By Histamine H3 Receptor Antagonists, 2021 - 2031F |
6.2 Israel Narcolepsy Drugs Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Narcolepsy Drugs Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.2.3 Israel Narcolepsy Drugs Market Revenues & Volume, By Capsule, 2021 - 2031F |
6.2.4 Israel Narcolepsy Drugs Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.2.5 Israel Narcolepsy Drugs Market Revenues & Volume, By Suspension, 2021 - 2031F |
6.2.6 Israel Narcolepsy Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Israel Narcolepsy Drugs Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Israel Narcolepsy Drugs Market Revenues & Volume, By Dopamine Regulation, 2021 - 2031F |
6.3.3 Israel Narcolepsy Drugs Market Revenues & Volume, By Orexin Activation, 2021 - 2031F |
6.3.4 Israel Narcolepsy Drugs Market Revenues & Volume, By Serotonin Modulation, 2021 - 2031F |
6.3.5 Israel Narcolepsy Drugs Market Revenues & Volume, By GABA Activation, 2021 - 2031F |
6.3.6 Israel Narcolepsy Drugs Market Revenues & Volume, By Histamine Regulation, 2021 - 2031F |
6.4 Israel Narcolepsy Drugs Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Israel Narcolepsy Drugs Market Revenues & Volume, By Adults, 2021 - 2031F |
6.4.3 Israel Narcolepsy Drugs Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.4.4 Israel Narcolepsy Drugs Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.4.5 Israel Narcolepsy Drugs Market Revenues & Volume, By Children, 2021 - 2031F |
6.4.6 Israel Narcolepsy Drugs Market Revenues & Volume, By All Ages, 2021 - 2031F |
6.5 Israel Narcolepsy Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Narcolepsy Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.3 Israel Narcolepsy Drugs Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.4 Israel Narcolepsy Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.5 Israel Narcolepsy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.5.6 Israel Narcolepsy Drugs Market Revenues & Volume, By Prescription Only, 2021 - 2031F |
7 Israel Narcolepsy Drugs Market Import-Export Trade Statistics |
7.1 Israel Narcolepsy Drugs Market Export to Major Countries |
7.2 Israel Narcolepsy Drugs Market Imports from Major Countries |
8 Israel Narcolepsy Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for new narcolepsy drugs in Israel |
8.2 Adoption rate of innovative treatment approaches for narcolepsy in the Israeli healthcare system |
8.3 Patient satisfaction and adherence rates with narcolepsy drug therapies |
9 Israel Narcolepsy Drugs Market - Opportunity Assessment |
9.1 Israel Narcolepsy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Narcolepsy Drugs Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Israel Narcolepsy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Israel Narcolepsy Drugs Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Israel Narcolepsy Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Narcolepsy Drugs Market - Competitive Landscape |
10.1 Israel Narcolepsy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Narcolepsy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here